Longitude Capital
Menlo Park, Californialongitudecapital.com
Overview
Longitude Capital is a leading healthcare venture capital firm that invests in transformative biotechnology, medical technology, and health solutions companies seeking to improve clinical outcomes, enhance quality of life, and drive efficiency of healthcare delivery. Founded in 2006, Longitude Capital invests in both privately held and publicly traded companies through a variety of investment approaches.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quanta Therapeutics | Jun 2026 | Series D | Co-investor |
| cAMPfield Therapeutics | Jun 2026 | Series A | Co-investor |
| cAMPfield Therapeutics | May 2026 | Series A | Co-investor |
| Endogenex | Mar 2026 | Series C Extension | Co-investor |
| AirNexis Therapeutics | Mar 2026 | Series A | Co-investor |
Key People
Juliet Tammenoms Bakker
Co-Founder, Managing Director
Fran Morilak
Senior Partner
Trudy Vanhove
Venture Partner
Victoria Lai
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
